Aaron Kimball - 01 Mar 2022 Form 4 Insider Report for Zymergen Inc.

Role: Chief Technology Officer
Signature: /s/ Natalie Dement, attorney-in-fact
Issuer symbol: N/A
Transactions as of: 01 Mar 2022
Net transactions value: -$95,345
Form type: 4
Filing time: 03 Mar 2022, 17:33:57 UTC
Previous filing: 03 Feb 2022
Next filing: 05 Apr 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ZY	Common Stock	Sale	$95,345	-25,000	-3.2%	$3.81	745,283	01 Mar 2022	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 17, 2021.
F2	Transaction executed in multiple trades at prices ranging from $3.76 to $3.92 per share, inclusive. The price reported in column 4 above reflects the weighted average sale price per share. The Reporting Person hereby undertakes to provide the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Content

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 17, 2021.

Transaction executed in multiple trades at prices ranging from $3.76 to $3.92 per share, inclusive. The price reported in column 4 above reflects the weighted average sale price per share. The Reporting Person hereby undertakes to provide the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.